NCT04504422

Brief Summary

The purpose of this study is to investigate the optimal stimulation location of transcranial direct current stimulation to improve the dual-task performance in patients with Parkinson's disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 7, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

November 5, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

3.3 years

First QC Date

August 5, 2020

Last Update Submit

February 15, 2024

Conditions

Keywords

Parkinson Diseasetranscranial direct current stimulationdual-task performance

Outcome Measures

Primary Outcomes (2)

  • Cognitive dual-task interference (%) in Timed-up & go test

    Percentage of dual-task interference calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]

    Immediately after a 20-minute tDCS session

  • Physical dual-task interference (%) in Timed-up & go test

    Percentage of dual-task interference calculated by the difference between dual-task and single-task performance \[Percentage of dual-task interference=(Dual-task performance - Single-task performance)/Single-task performance\]

    Immediately after a 20-minute tDCS session

Secondary Outcomes (6)

  • Timed-up & go test (sec): single task

    Immediately after a 20-minute tDCS session

  • Timed-up & go test (sec): cognitive dual-task

    Immediately after a 20-minute tDCS session

  • Timed-up & go test (sec): physical dual-task

    Immediately after a 20-minute tDCS session

  • Stroop test

    Immediately after a 20-minute tDCS session

  • Trail making test

    Immediately after a 20-minute tDCS session

  • +1 more secondary outcomes

Study Arms (4)

Primary motor cortex

EXPERIMENTAL

The anodic electrode is positioned in the primary motor cortex (Cz) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.

Device: transcranial Direct Current Stimulation (tDCS)

Left dorsolateral prefrontal cortex

EXPERIMENTAL

The anodic electrode is positioned in the left dorsolateral prefrontal cortex (F3) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.

Device: transcranial Direct Current Stimulation (tDCS)

Ventromedial prefrontal cortex

EXPERIMENTAL

The anodic electrode is positioned in the ventromedial prefrontal cortex (Fpz) and the cathode electrode on the left dorsolateral prefrontal cortex (F4). The current increases to 2.0 mA over a period of 30 seconds, maintains 2.0 mA for 19 minutes, and decreases to 0 mA over 30 seconds.

Device: transcranial Direct Current Stimulation (tDCS)

Sham stimulation

SHAM COMPARATOR

The anodic electrode is positioned in the primary motor cortex (Cz) and the cathode electrode on the right orbital frontal cortex (Fp2). The current increases to 2.0 mA during first 30 seconds, decreases to 0 mA over 30 seconds, and then stops supplying for 19 minutes.

Device: transcranial Direct Current Stimulation (tDCS)

Interventions

tDCS was applied for 20 minutes through two saline-soaked sponge electrodes (diameter 6cm) using the YMS-201B (Ybrain Inc, South Korea).

Left dorsolateral prefrontal cortexPrimary motor cortexSham stimulationVentromedial prefrontal cortex

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically diagnosed as idiopathic Parkinson's disease
  • modified Hoehn \& Yahr stage 2, 2.5, or 3

You may not qualify if:

  • History of seizure
  • Metallic implants, such as cardiac pacemaker or an artificial cochlea
  • Patients with inflammation, burns, or wounds in the stimulation area
  • Parkinson's disease dementia; cut-off is \< 7 of Korean-Montreal Cognitive Assessment for illiterate patients, \< 13 for those educated for 0.5-3 years, \< 16 for 4-6 years of education, \< 19 for 7-9 years of education, and \< 20 for 10 or more years of education.
  • Severe dyskinesia or severe on-off phenomenon
  • Plan to adjust medication at the time of screening
  • Sensory abnormalities of the lower extremities, other neurological or orthopedic disease affecting lower extremities, or severe cardiovascular diseases
  • Vestibular disease or paroxysmal vertigo
  • Pregnant or lactating patients
  • Other comorbidities that make it difficult to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Han Gil Seo, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 5, 2020

First Posted

August 7, 2020

Study Start

November 5, 2020

Primary Completion

February 13, 2024

Study Completion

February 13, 2024

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations